Global Blood Therapeutics Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (13)

Latest Posts

About This Stock More About This Stock
Global Blood Therapeutics Prices A $100.0 Million Common Stock Public Offering
Article By: NASDAQ GlobeNewswire
Friday, December 15, 2017 9:49 AM EST
Global Blood Therapeutics, Inc. today announced the pricing of its underwritten public offering of its common stock for gross proceeds of approximately $100.0 million.
In this article: GBT
Read
10 Stocks To Soar In 2018
Article By: TipRanks
Wednesday, December 13, 2017 2:18 PM EST
The market is currently trading at record highs, boosted by the prospect of business-friendly tax reforms.
In this article: HRTX, LRCX, MSFT, AVGO, GBT
Read
Week In Review: China Pharma Cross-Border Deals
Article By: ChinaBio® Today
Saturday, January 16, 2016 12:50 PM EST
BioAtla LLC, a San Diego-Beijing biotech, raised $45 million from the Global BIO Impact Fund, a US bioscience investor. BioAtla will use the capital to develop its portfolio of Conditionally Active Biologic antibody therapeutics.
In this article: AGN, MDT, PFE, GBT
Read

PARTNER HEADLINES

Latest Tweets for $GBT

No tweets yet!